The pharmaceutical company boss under fire from Hillary Clinton and many others for jacking up the price of the drug Daraprim 5,000 percent overnight said Tuesday he will lower the cost of the life-saving drug.
Martin Shkreli did not say what the new price would be but expected a determination to be made over the next few weeks.
20:56 Trump Transition: Jon Huntsman, John Bolton, Exxon CEO Among State Department Possibilities38
16:17 Why analysts think Kevin Johnson is the right replacement for Starbucks CEO Howard Schultz13
12:43 Outgoing Starbucks CEO Howard Schultz: Kevin Johnson better prepared to be CEO15
06:01 As Schultz Steps Down, Next Starbucks CEO Brings Tech Savvy14